跳至主要内容
临床试验/NCT04598243
NCT04598243Unknown早期 1 期

Treatment of Fibromyalgia and CFS With Ribose, Ashwagandha, Rhodiola, Licorice, Schisandra and Green Tea Extract

Practitioners Alliance Network2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2020年10月14日最近更新:
适应症

试验速览

阶段
早期 1 期
发起方
入组人数
70
试验地点
2
主要终点
VAS

研究概览

简要总结

Is a combination of Ribose, Ashwagandha, Rhodiola, Schisandra, licorice, and green tea extract helpful in CFS and FIbromyalgia?

详细描述

Ribose has been shown to be very helpful in CFS and fibromyalgia. Many studies have also shown benefit for the symptoms of these conditions from Ashwagandha, Rhodiola, Schisandra, licorice, and green tea extract. The study is undertaken as an early open label study to check for the efficacy of a proprietary combination of these

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • be diagnosed with CFS and/or fibromyalgia
  • live in the United States 3 - be over 18 years of age

排除标准

  • Hypertension

结局指标

主要结局

VAS

时间窗: 4-6 weeks

A composite VAS of Fatigue, Pain, Sleep, Cognition and overall well-being. These are each on a 1-10 scale with the same units, with 10 being healthy. The composite sum total of all of these (0-50) will be used as a single outcome measure

次要结局

未报告次要终点

研究者

发起方
Practitioners Alliance Network
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验